Ladies and gentlemen, thank you for standing by and welcome to the Second Quarter Fiscal 2019 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, today's conference is being recorded, Wednesday, December 19, 2018. I would now like to turn the conference over to Jeff Siemon, Vice President of Investor Relations. Please go ahead, sir.

Thanks, Jenifer, and good morning to everybody. I am joined here this morning by Jeff Harmening, our Chairman and CEO; and Don Mulligan, our CFO. In addition, Jon Nudi, who leads North America Retail segment, is joining us for the Q&A portion of the call. And I'll turn the call over to them in a moment, but before I do, I'll cover a few housekeeping items. Our press release on second quarter results was issued over the wire services earlier this morning, and you can find the release and a copy of our slides that supplement our remarks this morning on the Investor Relations website. Please note that our remarks this morning will include forward-looking statements that are based on management's current views and assumptions and the second slide in today's presentation was factors that could cause our future results to be different than our current estimates. And with that, I'll turn you over to my colleagues, beginning with Jeff.

Thanks, Jeff, and good morning to everyone. I'll start this morning by offering some quick thoughts on our year-to-date performance. I'm pleased to say that our results through six months keep us on track to deliver our full year targets. Our cost and capital discipline drove profit growth ahead of our expectations in the first half of our fiscal year. Our job to do for the second half is very clear, and that is to accelerate our sales growth in our North America Retail and Pet segments, while we maintain our cost discipline, and we're confident in the plans we have to do just that. Now I'll turn it over to Don Mulligan to walk through our financial performance in the quarter. Then I'll come back to provide an update on our fiscal 2019 priorities and share a few highlights on our second half plans.

Thanks, Jeff and good morning, everyone. Let's jump right into our second quarter financial results on slide five. Net sales of $4.4 billion increased 7% in constant currency, including contributions from the Blue Buffalo acquisition. Organic net sales declined 1%. Strong cost discipline and positive net price realization and mix helped drive margin expansion, resulting in adjusted operating profit of $765 million, up 8% in constant currency. And adjusted diluted EPS of $0.85 increased 2% in constant currency, driven by higher adjusted operating profit and a lower effective tax rate, partially offset by higher net interest expense and higher average diluted shares outstanding in the quarter. Slide six shows the components of net sales growth in the quarter. Organic net sales were down 1%, driven by lower contributions from pound volume, partially offset by positive net price realization and mix across all segments. Foreign currency translation resulted in a 2 point headwind to net sales and Blue Buffalo added 8 points to net sales. Turning to our segment results on slide seven, North America Retail net sales were down 3% as reported and on an organic basis. Consumer takeaway was stronger with U.S. Nielsen-measured retail sales down 1% and share gains in the majority of our top U.S. categories. Through six months, our shipments have lagged consumer takeaway by about 1 point, with organic net sales down 2% and U.S. retail sales down 1%. The main drivers of that difference with a comparison against last year's results that included co-packing sales related to the Green Giant divestiture, changes in customer inventory levels and minor differences in the phasing of trade between the first and second half. Looking ahead to the rest of the year, we expect our shipments to track more closely to consumer takeaway. Looking at operating profit performance…

Thanks, Don. And on slide 18, you can see the three key priorities we laid out at the beginning of our fiscal year, grow the core, successfully transition Blue Buffalo, and deliver our financial commitments. Let me share our progress on each of these priorities through the first half of our year. At our Investor Day in July, we outlined five keys to growing the core. And I'm pleased to say that through six months we've improved in each of these five areas relative to fiscal 2018. We returned to market share growth and U.S. Yogurt, year-to-date organic net sales in our emerging markets were up high single-digits. We were seeing good results from our first half innovation and our U.S. distribution trends have improved and we grew our share of distribution in the second quarter. And we're seeing a step up and contributions from organic price and mix, from 1 point in fiscal to 2 points through the first half of 2019. Through the first half of this year price mix has contributed to net sales growth across each of our reporting segments. In North America Retail, price mix contributed 2 points of sales growth, which is in line with the results we're seeing in the broader industry. In fact, 8 of the top 10 U.S. Food and Beverage manufacturers have generated positive price mix so far this year, including General Mills. We anticipate the strategic revenue measurement actions we implemented in the first half will continue to benefit our results as we move to the second half. We're competing well across most categories this year as measured by our market share performance. On slide 20, you can see that we grew share in six of our nine largest U.S. categories in the first half. However, we know there's…

[Operator instructions] Our first question comes from the line of Ken Goldman with JPMorgan. Please proceed with your question.

Hi, good morning everyone. Thank you.

Good morning, Ken.

If I could ask one on Blue Buffalo and then one on costs, when Buff first went into the FDM channel, it was obviously some blowback from legacy customers as expected. Now you're adding some more varieties into FDM, could you talk a little bit about what that means? Are you adding wilderness? Can you talk about what you're modeling in terms of additional maybe negative reactions from legacy customers as you do add these varieties? I want to get a little more sense of what actually the products are going and where those products are going?

Okay. And thanks for the question, Ken. I'll give you some level of specificity, but maybe not all the way to what you see. What I would say is that in terms of varieties, we do plan a significant expansion of varieties. And one of the things I'm most pleased with is that given the success we've had in Food, Drug and Mass so far, we'll see a lot of variety expansion and it will be highly incremental to what we currently have. And I think that strength -- that speaks to the strength of the Blue Buffalo brand in FDM and the success we've had in rolling it out, not only in terms of distribution growth, but actually maintaining and even growing the sales in places where we have it. I think that's probably the most important takeaway. In terms of Pet Specialty, I mean, we've declined double-digits, and look, where we're not happy with that long term trajectory. On the other hand it's what we modeled it would happen. And so it's kind of in line with our expectations. We're dedicated to the Pet Specialty channel for the long term. And what's interesting is that in some Pet Specialty customers that have continued to feature Blue and have distribution and go with our innovation and promotion plans their categories are actually doing better than those that haven't. And so we think -- and which just not a surprise given that Blue Buffalo is two times the next largest brand in that channel. And so we think we haven't modeled our Pet Specialty business to increase for the rest of the year, but we're certainly hopeful over time that it can and we know what it will take, it will take really good innovation, it will take partnering with our accounts to keep the in-store experience what it always has been, which is one of the point I think of competitive advantage and good promotion plan. And so, we haven't counted on our performance improving in Pet Specialty, but we're certainly dedicated to the channel and we're optimistic that we can actually turn that performance around over time.

Okay. Thank you for that. And then my follow-up is a few quarters ago, I think it's fair to say Mills ran into some bumps regarding cost visibility or especially on the transportation and logistics side. Can you walk us through a little bit which improvements you’ve made toward improving this visibility? One of the things I hear from some people is that they sort of got burned that quarter a little bit in there they are just a little bit nervous about being confident in your cost visibility there. And then along those lines, are you seeing any easing in your freight expenses ahead? Yeah we've seen spot transport rates peak and at least temporarily and oil prices are certainly down. So any color there would be helpful?

Sure Ken, this is Don. We did -- you're exactly right. We ran into above but we didn't have the visibility we needed. We made some changes from a systems and a process and a information flow standpoint internally to make sure that we are getting the sufficiently granular look at what the costs are. It also made sure that we are talking about what were the drivers not just what were the numbers what were the driver so we had a better sense of how they could evolve overtime what the range of potential outcomes were. And that is -- the combination of those things has given us much greater visibility into our cost structure. And it's one of the reasons that it's allowed us to over perform on the bottom line. We came ahead of our plan in the first quarter, we essentially matched our plan in the second quarter. So exiting the first half slightly ahead of the bottom line. And I think all that -- all the work that we did on the systems and the process and the information flow has paid dividends to help support that. As far as inflation, we're still expecting 5% across the company for the full year same as we guided. There obviously has been some movements up and down over the course of the year with tariffs and just harvest and so forth, but in total, we're still at 5%. And as far as logistics and are our freight costs in particular, we still see those being up double-digits, as we talked in some detail last year. We do annual contracts that are tied to our fiscal year and that contract this year reflected the higher in-market costs, which again we expect to see it throughout the balance of our fiscal.

Great. Thanks, Don.

Our next question comes from the line of Chris Growe with Stifel. Please proceed with your question.

Hey, Chris.

Hi good morning. I just had a couple questions for you, if I could. I did want to ask you had a number of factors that aided your gross margin performance in the quarter was better than I expected as well. I just was curious did pricing and I guess your overall SRM initiatives did those get to a point where they overcame cost inflation in the quarter that is your pricing mix and promo. And then I'm just curious what's the promotional spending kind of variation in the business, I'm thinking like the U.S. Cereal. How does that -- does that flatter the gross margin, but obviously it could hurt sales and will that kind of reverse in the second half of the year?

Well, yes. So year-to-date -- in the second quarter, we had operating margins of about 40 basis points ahead of last year gross margins were about 10 points ahead of last year. And there was really three key contributors, one obviously was the addition of Blue Buffalo which is the higher margin business both in the gross margin and the operating margin level. We talked about tight cost controls that was in the plans, it was in our administrative functions and that was a benefit to the operating profit, benefit to the gross margin. And then HMM and price mix together more than offset our input cost inflation. And those three Blue Buffalo, the ongoing cost controls and HMM price versus inflation that contributed in equal measure to our over performance and our growth in operating margin in the second quarter. Obviously was offset -- there was some offset from lower volume and the deleverage that we saw there, but those were the three primary drivers of the improved performance, they were about in equal measure. And so we are seeing the benefits of our SRM activities come through.

And the second part of your question, Chris, I think is also important as we think about the second half of the year and price and mix and look we realized about 2% price mix in the first half and we'll think -- and importantly we realized it across all segments. So I think that's important. And we see continued benefits from price and mix in the second half of the year and I mean I suppose if you're listening and you hear us talking about needing to make sure our merchandising on cereals and snacks a little more competitive you might wonder, okay, does that mean we're going take a margin hit in the second half or can we generate pricing. And the answer is look we're talking about two specific categories, the rest of our top [8] [ph] our pricing is in good shape. And for the rest of the company we feel like we've got good pricing plans in place. On top of that something you might not think about, but certainly we do is that on an enterprise level to the extent that we grow Blue Buffalo double-digits in the back half with we have a great line of sight to doing and we pick up our growth on cereal and snacks, there is a net price mix at the enterprise level even without taking pricing because the price per pound that we get from pet and from cereal and from snacks and as well as actually some of the other accelerate categories like Haagen-Dazs and Old El Paso they're better than the company average. And so as we look at the back half of the year we see an ability to continue to generate price and mix in the marketplace.

Okay, thank you. That’s helpful. And I just had one quick follow-up for you on cereal, you gave the consumption data by month and negative 3, negative 2 [in cereal] [ph] better throughout the quarter. Your cereal sales are down 5% obviously there was a bit of a gap there and I'm sure it's driven by the promotional cadence. Are inventories do they had to rebuild or they at the right level here from this point going forward?

Hey, Chris, its Jon. One of the things to keep in mind last year in Q2 cereal RNS was up 7%. So again we've got a tough comp there. Overall, we bought some inventory through the first half across U.S. Retail and cereal is a part of that and we expect as we move through the back half of the year that won't be as big of a headwind. So again we think the comps get better for us. Our merchandising will come back and we believe that we'll have a much stronger back half from a cereal standpoint.

Okay, thank you.

Our next question comes from the line of Robert Moskow with Credit Suisse. Please proceed with your question.

Hi, thanks. I guess, I have two questions. One is on Blue Buffalo, sales in second quarter were lower sequentially than first and I guess that's the result of things getting a little weaker in the specialty channel. Is that a fair assessment? And then secondly, when you launch it in this big retailer and double the ACV, how comfortable are you that these are completely incremental sales like there must be Pet consumers who are going to shift their channel of shopping from one channel to the other. What's the algorithm on that in terms of incrementality that you've seen historically? And then the last part about that incremental question I guess is you talked about wet and treats, is Blue really good at wet dog food, is it really good at pet treats? And, what's the durability of these types of extensions because those areas, I guess, aren't exactly what consumers are familiar with from the core Blue? Thanks.

Hey Rob, this is Jeff and you asked a number of questions and let me make sure I hit, if I don't hit all of them, it’s not because I have tried avoid I just forgot one. So let me try to hit them kind of sequentially. In terms of the second quarter the slowdown in reporting net sales, it actually isn’t fair to say that it was a slowdown in Pet Specialty or Pet Specialty declines were pretty much the same year-over-year. It really is a matter of our comparison to a year ago and inventory builds. And so the way I like to think of it in the second quarter of this year, we're comparing to 25% growth last year, we declined 7% this year. So over a couple year period that's about 9% compound annual growth. If you look at our takeaway in retail sales, it's about 9% compound annual growth. So it really the deceleration in RNS has nothing to do with takeaway and nothing to do with a decline -- further decline in Pet Specialty. It has everything to do with lumpiness of RNS as it relates to inventory build. We will see that reverse completely, in fact we will see it reverse completely and then some, in the back half of the year specifically in the fourth quarter starting in February as we build inventory in ahead of our new distribution gains. In terms of incrementality, one of the reasons why I mentioned household penetration is because there are a lot of numbers I can throw out about incrementality and we've done a lot of studies. But -- and what we found is that our launch into Food, Drug and Mass has been highly incremental, for the Blue Buffalo brand. But one of the…

Got it. All right. But, I guess, the question that I had about sequential is, is because I don't see a lot of seasonality in the business in pet food. Pet owners just keep feeding their dogs the same amount every time. So that's why I was looking at the sequential growth coming down. So is there any reason to believe that that's not the right way to look at it? Why would it seasonality matter?

Seasonality really doesn't matter much, you're right. Pets tend to eat about the same amount every day. And it really has to do -- I think the most important point Rob is to take away is this building of inventory and how it looks quarter-to-quarter. And that's why I get back to the retail consumption is being the main driver. Because I'm going to tell you, our fourth quarter is going to be really high and it's going to look really good for Blue Buffalo and it will be good. But we have to keep -- but the key is really making sure, we have the underlying consumption in mind.

Rob, this is Jeff Siemon. I’ve mentioned Q1 of a year ago for Blue Buffalo net sales grew in the low-teens, maybe close to 15%, Q2, it moved up to 25%. So that's why you see this year deceleration is really the acceleration you saw last year in the comp, driven by the Food, Drug and Mass launch. Q3 last year was about 15% growth in net sales and Q4 was only up low-single-digits. So again, you saw a lot of variability last year. As we comp that this year that will have variability and then as Jeff said, our Q4 as we expand Food, Drug and Mass, you'll see a big acceleration.

Okay, thank you.

Our next question comes from the line of Jason English with Goldman Sachs. Please proceed with your question.

Good morning folks. Thank you for letting me ask the question. I want to come back to margins and latter into the U.S. Retail segment. First going back to gross margins, just to make sure I kind of have the numbers right. We've got Buff adding maybe 80 bps or so. So underlying we're looking at down 70 bps, which looks like the math would suggest just the volume leverage is that roughly right?

Buffalo was probably little less than that in the quarter. It will be in that neighborhood for the full year even a little higher for the full year as we alluded to, when we announced the deal. But in the second quarter it was a little less than that just given the fact that we had some the volume deleverage and the inflation and plant startup cost in the number.

Got it.

But you’re directionally correct, pet added in the base business was slightly down on a gross margin basis year-over-year.

So it's not surprising to see the base business down a bit clearly it sequentially getting better, which is the right trajectory. I was surprised that you still had with base business gross margins down you still had as much margin leverage in North America Retail. Can you help me understand some of the drivers? And I guess where I'm also going to is this another quarter where you pulled back a lot on A&P. And if so, is there -- do you see any parallels with this sequentially eroding volume trend for now sort of the fourth quarter row with sort of consistent pullback on A&P?

No. What we saw in U.S. retailer NAR, was the same trends we saw from a total company standpoint. We have strong HMM, we have price mix benefit coming through. We had really strong cost control in our plants, so our manufacturing costs came in very tight and those combined to deliver better profitability of the bottom line than sales.

So it's not just marketing related then this sort of core underline is that the message?

I think it is. It really is a matter of Jason price mix and HMM exceeding inflation. And I think you see that because our second quarter it was our merchandising results that really lagged our expectations. What we sell at an everyday price was actually at or above our expectations and that's the best margin. And so from a margin standpoint we are really pleased with what we're selling at an everyday price. And what we merchandise was really what drove -- what was really the cause for our sales being a little below what we had anticipated, which has pretty good margin impact.

Just to build on what Jeff laid out, our baseline through the first half were flat in North America Retail which we feel really good about. It was really merchandising which was all of our declines and primarily in cereal and snacks. So we feel like our total commercial investments are in a really good place. We feel like our innovation is really working, our marketing is strong and the base business is performing. We clearly had some execution issues particularly on cereal and snacks merchandising and we've got plans in place to fix that. And you saw in November, cereal getting better as we got to merchandising more in line. So we have good confidence so we can accelerate the top line and at the same time continue to drive good margins in the back half.

Good stuff. Thanks guys. I'll pass it on.

Okay, thanks.

Our question comes from the line of Pablo Zuanic with FIG. Please proceed with your question. Mr. Zuanic, your line is open, please go ahead.

Thank you. Good morning, everyone. Two questions on pet food, the first one is more just a bigger picture. On the one hand as we see more premium pet food brands in Mass. We hear about consumer pushback about Walmart consumer $40,000 a year, now the interest on this type of products, but on the other hand clearly, more retailers are adding more space to premium pet food. So try to resolve that conflict for as a contradiction. And my visits to stores for example I would say Target these days seems to have eliminate a lot of the Mass brands and you are seeing allow more premium. So when you launch at these new retailers let's say including Walmart are other brands on the premium side also entering that aisle? So again the big picture question is trying to reconcile this idea of pushback on the consumer on this more expensive pet food, but on the other hand apparently a number of retailers continuing to add a greater percentage of space to premium pet food. Thanks.

Well, Pablo, I appreciate the question. I think, what we see is that first is as Blue has entered it has been really successful and in fact year-to-date it's driven something on the order of 40% of the growth in Food, Drug and Mass. And so this premium part of the Pet Food segment especially kind of the wholesome natural area Blue Buffalo is driving that growth. And interestingly, as Blue has come in to the Food, Drug and Mass segment it's actually grown the whole segment, so the whole segment is growing. And the customers that have taken Blue Buffalo are growing faster than the ones that haven’t. And so, what that says to me there is a premiumization going on in pet food similar to what we see in human food and what you see in -- what we've seen in natural and organic, so again the trends there are very similar. And we've had -- I think it also -- what it also speak to the success we've had with Blue Buffalo in Food, Drug and Mass as well as e-commerce by the way, is number one on online and it's number one in Pet Specialty. So it's doing well across channels and great brands do well across channels, and we see that with Cheerios and we see that with Annie's. And so what we're seeing in Blue is kind of what we expected and it's drive -- importantly it's driving success in the whole segment of wholesome natural and Food, Drug and Mass and it's really some of the mainstream brands that have seen declines.

Right. And just a follow-up, so pet coke [ph] has made some news in the trade press in terms of making significant assortment changes to a portfolio there taking out brands focusing on natural ingredients. Any impact on Blue Buffalo can you try to quantify the exposure for your business there.

We don't comment on any specific retailers, but I will say that all our brands are natural. And so we feel good about the ingredients in Blue Buffalo and certainly wouldn't anticipate any negative consequences from that activity.

Great, thank you.

Our next question comes from the line of John Baumgartner with Wells Fargo. Please proceed with your question.

Good morning, thanks for the question.

Hey, John.

Jon, I just wanted to come back to the softer merchandising in Q2. I mean there has been a lot of talk about shifting your approach to I guess more non-priced promo. And I'm curious as to how this influence performance. There was the softness kind of a function of competitors stepping with sharper elbows for per price promo or -- and you have to I guess increase your price promo going forward more than you thought or did the non-priced promo just see weaker lifts. Just curious on more the background there and the transition moving forward?

Sure John, great question. What I would say was there is really two specific categories and some specific issues within each, which drove to our merchandising softness. So for cereal, we executed a pack price architecture project through the first half that touched nearly 70% of our line. So was our major project on top of that we had capacity constraints in our flake cereals and combined the two cause some disruption in our execution particularly in the months of September and October. And we didn't get the merchandising that we had expected. We got back into business from a merchandising standpoint in November and we saw our business bounce back. For snacks, we've had capacity constraints on two of our major platforms there as well and also some timing shifts from major retailers from Q2 to Q3. So we feel really good about our ability to get merchandising and actually get back to plan from a merchandising standpoint that will shift out again from Q2 to Q3. You're starting to see it already again November was a much better month through two weeks of December the Nielsen that's out you can see that our momentum continues and we were actually up 1 overall in dollars. So it was really cereal and snacks that are specific drivers that again around the past we feel good about our ability to execute moving forward.

Great. And then just a follow-up for Don, in terms of some of the businesses that you're thinking about maybe selling some of the slower growth assets any update there in terms of timing or maybe what you're -- how the volatility of the market impact some of those plans going forward?

Yes, there's no update. We spoke in the past about looking at roughly 5% of our portfolio that still in line, but we don't have any update until we are ready to pull the trigger on something.

Great, thanks for your time.

Our next question comes from the line of Akshay Jagdale with Jefferies and Co. Please proceed with your question.

Good morning. Thanks for taking the question. So my first question is on Blue Buffalo. As far as the Mass or the FDM expansion goes I think it's well publicized now that there is a delay in the resets at one major retailer by about seven weeks or so. And so in light of that you've still maintained your guidance. So that leaves me to believe that you weren't really taking a lot of that in your guidance to begin with, but can you just help us understand some of the delays in shelf resets how that has impacted your numbers? And then related to that I think Jeff you made a comment about how the mix of that business is actually margin positive. I think there is a big disconnect in expectations on this -- on our side as to the FDM channel being sort of margin mix neutral to positive going forward.

Yes, so in terms of the second half distribution build, when we came into the year, it's fair to say that we assumed that we would have a big push in our distribution plans kind of at the end of January and for a variety of reasons that's going to be delayed by a few weeks to be honest in the life of a brand, it's not a big deal. What it means is that because it really starts in February now instead of January it pushes it into our fourth quarter instead of our third. But in terms of what it means for the brand to be honest it's not a huge deal. And what I would also say is that we have been -- while that delay may have impacted the year a little bit to the negative, our product expansion or variety expansion to other customers is going to be frankly the uptake on that is going to be better than we anticipated because Blue has been so strong and those initial customers we launched into a year ago. So when you get those things together, we'll have strong growth in Food, Drug and Mass for the year. So we feel really good about that. In terms of wet pet food and treats, if I understand your question correctly, the -- what we see is that there'll be a product mix in Food, Drug and Mass so it'll be a little bit different skew a little bit more toward the wet and treat segments where the profit margins are better. I mean, first of all, they're all good, all the profit margin in pet are good, certainly relative to General Mills average, those tend to be particularly good. And as we push into that that's one of the reasons our household penetration is up higher than our sales because as we expand into Food, Drug and Mass and also why it's incremental because we see a different product mix.

Perfect. And one follow-up maybe for Jon, it relates to North America and the recovery in the context of your guidance again, right. So you’ve maintain your sales growth guidance implies as pretty significant turnaround in the businesses in the back half. And you've pointed to some what I would call tactical changes or improvements, right? So can you help us understand how like better merchandising let's say on snacks could have a material impact like because it seems like that's what needs to happen to get to the top line numbers. Thanks.

Yes. So I'd say two things. One, again, as we look at the underlying health of our business through the first half, we feel good about it, as our bass lines were flat, distribution points are heading in the right direction, feel good about innovation and marketing. So the base business feel strong, it was really merchandising that we saw the midst of plan. And as I mentioned before, we have a good line of sight to getting that merchandising back into the back half. The other thing that I believe Don touched on in the prepared remarks is through the first half, there was a difference between what we reported in RNS and what Nielsen movement was. Some of the drivers there were the Green Giant comp that we had through the first half that goes away as we go into Q3 and into the back half. We did see some significant inventory reductions at some major customers in the first half. As we've had collaborative discussions with those customers, we don't believe that we’ll see another downshift in the back half of this year. And then finally, as Don mentioned, there were some trade phasing that some minor differences that were a bit of a headwind in the first half and become a more of a tailwind in the back half. So really, I think from an execution standpoint, if we get our merchandising where we expected to be continue the baseline strength we believe that we can be where we need to be to deliver for the company.

And I am going to build on that, I agree with everything that Jon said and I would build on it by saying. I mean, if you look at what we had done had in one of our slides. If you look at the first half of the year, our organic sales were flat. And our guidance for year was flat to up 1%. And so on our organic business, we don't need to jump out of our shoes in order to hit our guidance for the year. We need -- do we need to improve a little bit? Yes. But we don't need to improve so significantly that we feel like, we have to go out buy volume at any cost in the back half of the year to hit our sales guidance, that's not the case at all. We just need to improve a little bit in a couple of specific areas. The biggest improvement you're going to see in our back half of the year is going to be on Blue Buffalo. And you'll see that, because of the comps and in fact we are lapping the inventory from Q2 and we're not doing that again back half and we're doubling our distribution. That will be the biggest increase and we have very tangible plans in place in order to recognize that.

Thank you.

I think maybe we'll try to get one more on please.

Thank you. Our next question comes from the line with -- from David Driscoll with Citi. Please proceed with your question.

All right. Well, I appreciate making it in under the wire. Good morning.

Good morning, David.

Good morning, David.

I wanted to ask a few questions on Blue Buffalo. Can you guys quantify the growth in the wet treats and other and in dry food?

From a retail sales standpoint, if you look across channels we're seeing wet and treats growth in the 20% range. So well ahead of the total. So we feel really good about where we're seeing that and as Jeff said Food, Drug and Mass is where we're seeing particularly outperformance for wet and treats.

Okay. And then on dry, do you have any number that you can give us, of course that's the biggest piece of it. So I would assume that it was down related to the FDM launch from year ago. But any quantification you can give on that. Buff used to give that disclosures and I think it's pretty helpful.

Yes, David what I was just referencing were our retail sales not the net sales, right. Net sales were down and I actually don't have the split on net sales between dry wet and treats, but from a retail standpoint, again wet and treats were driving some nice growth. But in total with dry being the bulk of the business you still saw positive trends there.

But I think your instincts Dave are right about the business. I think your instincts are right in that. Because it was the inventory build in the Food, Drug and mass last year on the Life Protection Formula, big piece of which was dry. It's fair to assume that that business on a reported net sales basis didn't perform as well, because that's where we had the inventory builds. So I think your instincts are right even if we don't have the exact numbers in front of us right now I think your instincts are correct?

And then on the Wilderness brand. That's the second largest brand at the company. Can you make any comments about how that brand is growing?

Well, it's a first of all Wilderness is a great brand. And I think some of the best packaging we have at General Mills and some of the best equity. And I can tell you it's kind of a tail of two things, we don't have it in FDM at the moment, but in specialty it's doing okay, but it's declining a little bit because our business in Pet Specialty declining and e-commerce it’s on fire. So the fair amount of our growth in e-commerce is Wilderness as well as the Life Protection Formula, and what I can tell you that's a great sub line. And we think it has a lot of potential just like we think Life Protection Formula has still a lot of potential.

Okay. Two more Buff questions and then one question for, Don. The two final ones on Buff were just, I think you mentioned on your new product plans that you'd be launching new varieties. But just for clarity, are these new varieties in the marketplace in any marketplace or are these varieties that were in some channels previously and you’re moving those kind of existing varieties into FDM. I just want to be clear if it's really a new product or if it's existing product channel expansion?

It's fair to assume that it's existing products that we're expanding channels. So products with a proven track record of success that we are expanding.

Okay. And then for Don, two questions for you, one on the startup of the new plants for Blue Buffalo. Can you give us any quantification as to either the dollar expenses of these new startups, -- the plant startup costs on your P&L and or the gross margin impact, because in the past for Blue these were significant expenses. And then I have a debt question for you, just would like you to talk about your debt pay down plans, your debt to EBITDA target. And I believe you have $1 billion maturity in February. And I ask all this in light of what's happened to your dividend yield and get your thoughts there. Thank you.

Sure. Yes, in terms of Blue, plant startup if you see what the profit decline in the quarter, it was about a third from lower sales, a third from plant startup costs and a third from the impact of inflation. And so to your point, it was a significant factor and that’s something that we will roll through as the year unfolds. So that's I think your recollection of the impact is correct. As far as debt, year-to-date from end of the year till now our debt is down about $500 million. We do have that maturity coming up. So we’ll have the opportunity to bring that down further in the back half of the year, not by the full billion, but by some additional amount. And we still target to exit F2020 with our leverage ratio at 3.5 which is what we announced at the time of the deal.

Thanks. I appreciate the comments. Thank you and happy holidays.

Happy holidays.

Thank you, David.

And that's all the time we have. Thanks everyone for hanging with us. Appreciate all the good questions and please reach out with further questions, we're around all day. Thanks so much. Have a great holiday season.

Ladies and gentlemen this does conclude today's conference call. We thank you for your participation and ask that you kindly disconnect your lines.